IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
B-cell Chronic Lymphocytic Leukemia
Zulfa Omermonoclonal_antibodyPhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 63/ 100
- Competitive Position
- 89/ 100
Competitive context
71 Active assets in the B-cell Chronic Lymphocytic Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Humax-Cd20 Emory University | Phase 4 | BBB |
Acalabrutinib Zulfa Omer | Phase 4 | BBB |
Fludarabine Ohio State University Comprehensive Cancer Center | Phase 4 | BBB |
Cyclophosphamide Ohio State University Comprehensive Cancer Center | Phase 4 | BBB |
Cediranib City of Hope Medical Center | Phase 2 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →